Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response - Wikidata - thesis-toulmin - TriplyDB

Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response

Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response

http://www.wikidata.org/entity/Q24681387

about

Antiviral activities of ISG20 in positive-strand RNA virus infections Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1 Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling New insights into the role of RNase L in innate immunity Restricting retrotransposons: a review The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA Innate immune responses in hepatitis C virus infection Coronavirus gene 7 counteracts host defenses and modulates virus virulence Interferon-inducible antiviral effectors Activation and modulation of antiviral and apoptotic genes in pigs infected with classical swine fever viruses of high, moderate or low virulence Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity Crystal structure of the mouse hepatitis virus ns2 phosphodiesterase domain that antagonizes RNase L activation Modulation of the Translational Landscape During Herpesvirus Infection Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control Functions of the influenza A virus NS1 protein in antiviral defense Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis RNase L restricts the mobility of engineered retrotransposons in cultured human cells A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L Activation of IFN-β expression by a viral mRNA through RNase L and MDA5 Influenza A induced cellular signal transduction pathways.Molecular epidemiology of influenza A virus infection in Cyprus in four consecutive seasons (2009 pandemic-2013).Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses.The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors.Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1.Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner.RNase L targets distinct sites in influenza A virus RNAs.RNase L mediated protection from virus induced demyelination.Innate immune evasion strategies of influenza viruses Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells.The Association of OASL and Type I Interferons in the Pathogenesis and Survival of Intracellular Replicating Bacterial Species.Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients.Influenza-induced production of interferon-alpha is defective in geriatric individuals.Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function Innate immunity to influenza virus infection.

P2860

Q24305035-1E0A73F9-0FB0-4564-A911-1B3D1C424F34 Q24309199-D0678329-67D1-4910-B049-2E87DAE641B4 Q24594497-66C5E366-48BE-443E-A232-F6D6037A9A99 Q24597466-AC73567A-E98D-415D-9EB9-CFA5AE06006F Q26741496-EB397AA9-99C8-4FC6-AA84-380680D1FFB4 Q26772138-F8AFA5D8-5301-42A4-B54B-37095B34209D Q26800446-F153869D-D868-4F47-A38B-110273830B91 Q27023055-320D1D59-1B1F-493A-AF41-8E105C250A14 Q27349527-3A37289E-00D4-43BD-90E4-CE33283FE27D Q27486790-783C258F-59A9-4CC4-BF55-3F84E888B96D Q27489617-D7AB772E-E8B0-4354-85D9-AA6849A7B09E Q27640568-D04D4F74-C54A-4F40-A17E-4D9D8DC9F7AE Q27681451-AB211466-EAF3-4F5E-903C-A8DADA856561 Q27703597-F6798C42-3299-4084-892A-5184960F6B32 Q28078469-8C1471B8-97D6-41EE-9CF8-85707C5E1108 Q28082128-001DC570-FD79-414A-BCA3-0AFAA3537185 Q28083893-6D74C2D0-1EE4-4E0B-AD32-80DEF3C5EF61 Q28259436-C0469D8F-D6FC-463D-B1FE-CF6EE8796327 Q28660459-EF77041C-8274-4F80-A397-229053BB8317 Q28754508-945E4FB7-8B55-4642-AEB5-471E4C7FEF47 Q29395694-B47C3FB8-9C19-4E98-AA50-0733D75DA7FD Q30353167-D8BD9289-26F5-44E0-A27C-12D48C81054C Q30354880-7D613560-723B-4E4E-A4F4-3CC455980AD9 Q30357014-6C94C142-A73B-4AC1-A400-BDCE48CD33C8 Q30358265-F067A1BE-ADA3-4259-810C-896F89289F52 Q30375457-8433F0DB-DD9D-4A8B-A0CA-77C5C1BA2850 Q30407137-B93FA401-6B2C-4F7F-A068-ED2FA05AA48B Q30429134-1679ACD6-21E0-4A28-A9E0-2F46D4205282 Q30620296-249210C5-7038-4718-BF26-FF6E136D0BFF Q33508237-CA204272-893D-4524-86D1-65361180130F Q33646273-793DFCB0-5DFE-4967-A93C-03C28BB46C78 Q33648964-BEE301A5-8189-4001-A278-20B99CEB73DD Q33707052-F5FC2BE0-2730-4EBB-B0C1-62EC3A775D26 Q33714369-8713F7EF-A263-4CE6-A3F7-94BB0A753FF4 Q33753944-2BE6E3C1-164C-4185-B35C-1332EDF78515 Q33785818-8B1AF1F5-14B1-40EB-BC74-646DB1BA6811 Q33871391-D9F4899B-9E1D-4CBA-9202-A7B30EAB5661 Q33877299-6DED209E-4CFD-42D7-86F0-D56CD94D8622 Q33899677-82E82018-A034-41CF-815F-D954F622D0AE Q33923354-F161063C-8CA5-4EEE-B8AC-2D1401FBAA25

P2860

Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response

http://www.wikidata.org/entity/Q24681387

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Viral encounters with 2',5'-ol ...... interferon antiviral response

@ast

Viral encounters with 2',5'-ol ...... interferon antiviral response

@en

Viral encounters with 2',5'-ol ...... interferon antiviral response

@nl

type

label

Viral encounters with 2',5'-ol ...... interferon antiviral response

@ast

Viral encounters with 2',5'-ol ...... interferon antiviral response

@en

Viral encounters with 2',5'-ol ...... interferon antiviral response

@nl

altLabel

Viral Encounters with 2',5'-Ol ...... Interferon Antiviral Response

@en

prefLabel

Viral encounters with 2',5'-ol ...... interferon antiviral response

@ast

Viral encounters with 2',5'-ol ...... interferon antiviral response

@en

Viral encounters with 2',5'-ol ...... interferon antiviral response

@nl

P1433

Q24681387-774D8AC9-6D2C-4200-B7A6-888A8609ABBA

P1476

Q24681387-EF7BB474-91B0-4CE6-ACA9-C920A2FCCEDB

P2093

Q24681387-F32FD000-F790-467E-B162-36EE02026EDF

P2860

Q24681387-015E873E-F054-49EC-B25E-CF411395083B

Q24681387-0368B123-2491-4E4E-BDE7-DA3EDDAE8B2B

Q24681387-040D4BE0-BEDE-4322-BFCD-4766A03A4D0C

Q24681387-041EA747-3DF6-4CE6-923B-1A3F70993CBC

Q24681387-0AED2EF5-086D-465A-9366-53E0D1F89451

Q24681387-0C630B82-3FB5-4D68-873B-8F746D1525AC

Q24681387-0DCE0015-6BB7-4527-97B2-B056C19565DD

Q24681387-0EACBB53-F141-4D53-96F4-E23B71D1A04A

Q24681387-1591DEEF-AE66-478A-B805-65EEAABFC14C

Q24681387-188C94BF-D5B9-4525-8D4A-A116AFC01449

P304

Q24681387-C7309978-E62C-424C-93C1-08E694B2D3E8

P31

Q24681387-DD48B775-C913-4991-9D5B-E0F9F0D6CE27

P3181

Q24681387-A4156105-29CB-4888-A5E2-6B1F192B9ECD

P356

Q24681387-00FFFCD1-5391-4037-A34E-ADF62AACE4DD

P407

Q24681387-3B00A0EB-0222-46DF-AB75-4A11E35167CE

P433

Q24681387-796467EC-A480-4505-9E04-F9241EDF70C7

P478

Q24681387-17514A64-9C9E-4F53-8B5F-2E0C1EB585FF

P577

Q24681387-59DCBE3D-452B-4B42-BB5E-4AB8B272C592

P698

Q24681387-8A6494D1-DE57-4501-B727-BFD60144A9AD

P932

Q24681387-5ACF9357-2347-47DF-84B3-B9F23353C9C6

P3181

P356

P1433

Journal of Virology

P1476

Viral encounters with 2',5'-ol ...... interferon antiviral response

@en

P2093

Robert H Silverman

http://www.w3.org/2001/XMLSchema#string

P2860

RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway

p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase family

Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene

A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon

A new pathway of translational regulation mediated by eukaryotic initiation factor 3

Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinant

Positional cloning of the murine flavivirus resistance gene

P304

12720-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2366484

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01471-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17804500

http://www.w3.org/2001/XMLSchema#string

P932

2169107

http://www.w3.org/2001/XMLSchema#string